We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of h... read more Featured Products: More products

Download Mobile App




Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business

By MedImaging International staff writers
Posted on 22 Oct 2024
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Gynesonics (Redwood City, CA, USA) for approximately USD 350 million, subject to working capital and other customary closing adjustments.

Gynesonics is a privately held medical device company dedicated to developing minimally invasive solutions for women’s health. The company pioneered and launched the Sonata System, which is the first FDA-cleared medical device designed for diagnostic intrauterine imaging and transcervical treatment of specific symptomatic uterine fibroids, including those linked to heavy menstrual bleeding. The Sonata System is unique as the world’s first and only intrauterine fibroid ablation system that combines the safety of ultrasound guidance with the established benefits of targeted radiofrequency energy, all within a single transcervical, incision-less procedure. The transcervical delivery method avoids entering the peritoneal cavity and does not necessitate general anesthesia. The Sonata System is capable of treating most types of fibroids, including submucous, intramural, transmural, and subserous fibroids, providing a groundbreaking alternative to traditional hysterectomy and myomectomy. The acquisition of Gynesonics strengthens Hologic’s innovative portfolio of medical technologies that effectively detect, diagnose, and treat women's health conditions.

“Gynesonics’ Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids,” said Brandon Schnittker, Division President of Surgical Solutions at Hologic. “This acquisition furthers our commitment to providing women with minimally invasive treatment options. We are enthusiastic about the future as we work to expand access to and drive innovation for treatments that enhance women’s quality of life.”

Related Links:
Hologic
Gynesonics

Pocket Fetal Doppler
CONTEC10C/CL
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Digital Color Doppler Ultrasound System
MS22Plus
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.